Derica W Rice
CIK 1359067 · EVP & President, CVS Caremark · last filed 2026-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LLY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
TPS-3155
MINNEAPOLIS, MN 55403
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BMY | Director | — | $62.14 | — | $0 | 33 | 2026-10-02 |
| DIS | Director | 24,893 | $116.75 | $2.91M | $0 | 31 | 2026-10-02 |
| CG | Director | 37,917 | $39.70 | $1.51M | $0 | 6 | 2026-05-01 |
| TGT | Director | 14,622 | $158.41 | $2.32M | $0 | 19 | 2026-03-13 |
| CVS | EVP & President, CVS Caremark | 26,827 | $83.85 | $2.25M | $0 | 3 | 2020-03-03 |
| LLY | EVP-Global Services and CFO | 44,089 | $1354.00 | $59.70M | -$5.95M | 28 | 2017-02-03 |
Recent Filings · Page 11 of 12
120 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-02 | LLY | Mixed | +30,623 | -$2.28M | EDGAR |
| 2012-01-30 | LLY | Grant (A) | +25,573 | $1.01M | EDGAR |
| 2012-01-13 | TGT | Grant (A) | +5,320 | $0 | EDGAR |
| 2011-02-17 | LLY | Sell (S) | −12,441 | -$429.8K | EDGAR |
| 2011-02-03 | LLY | Mixed | +51,902 | -$1.08M | EDGAR |
| 2011-01-27 | LLY | Grant (A) | — | $0 | EDGAR |
| 2011-01-14 | TGT | Grant (A) | +4,418 | $0 | EDGAR |
| 2010-02-04 | LLY | Sell (S) | −8,200 | -$288.9K | EDGAR |
| 2010-02-03 | LLY | Mixed | +27,043 | -$491.3K | EDGAR |
| 2010-01-28 | LLY | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.